Kenneth M. Kozloff, Ph.D.

Affiliations: 
2005 University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Molecular and Cellular Biomechanics, Organ and Whole Body Biomechanics, Tissue Engineering and Regenerative Medicine
Google:
"Kenneth Kozloff"
Mean distance: 9.03
 

Parents

Sign in to add mentor
Steven A. Goldstein grad student 2005 University of Michigan
 (Influence of a collagen mutation of the mechanical nature of bone: Governing factors in a disease model for osteogenesis imperfecta type IV.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Surowiec RK, Battle LF, Schlecht SH, et al. (2020) Gene Expression Profile and Acute Gene Expression Response to Sclerostin Inhibition in Osteogenesis Imperfecta Bone. Jbmr Plus. 4: e10377
Cabral WA, Fratzl-Zelman N, Weis M, et al. (2020) Substitution of murine type I collagen A1 3-hydroxylation site alters matrix structure but does not recapitulate osteogenesis imperfecta bone dysplasia. Matrix Biology : Journal of the International Society For Matrix Biology
Varga P, Willie BM, Stephan C, et al. (2020) Finite element analysis of bone strength in osteogenesis imperfecta. Bone. 133: 115250
Surowiec RK, Battle LF, Ward FS, et al. (2019) A Xenograft Model to Evaluate the Bone Forming Effects of Sclerostin Antibody in Human Bone Derived from Pediatric Osteogenesis Imperfecta Patients. Bone. 115118
Scheiber AL, Barton DK, Khoury BM, et al. (2019) Sclerostin Antibody-Induced Changes in Bone Mass are Site Specific in Developing Crania. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research
Olvera D, Stolzenfeld R, Fisher E, et al. (2019) Pamidronate Administration during Pregnancy and Lactation Induces Temporal Preservation of Maternal Bone Mass in a Mouse Model of Osteogenesis Imperfecta. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research
Olvera D, Stolzenfeld R, Marini JC, et al. (2018) Low dose of bisphosphonate enhances sclerostin antibody-induced trabecular bone mass gains in Brtl/+ osteogenesis imperfecta mouse model. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research
Marini JC, Forlino A, Bächinger HP, et al. (2017) Osteogenesis imperfecta. Nature Reviews. Disease Primers. 3: 17052
Perosky JE, Khoury BM, Jenks TN, et al. (2016) Single dose of bisphosphonate preserves gains in bone mass following cessation of sclerostin antibody in Brtl/+ osteogenesis imperfecta model. Bone
Sinder BP, Lloyd WR, Salemi JD, et al. (2016) Effect of anti-sclerostin therapy and osteogenesis imperfecta on tissue-level properties in growing and adult mice while controlling for tissue age. Bone
See more...